Anida, ALS Therapy Development Institute (ALS TDI) deal

The not-for-profit partnered with Anida to evaluate Anida's preclinical compound, neuroprotectin D1 ( NPD1), in superoxide dismutase 1 (SOD1) mice as a potential treatment for amyotrophic lateral sc...